Medico Remedies
BSE: 540937 | NSE: MEDICO | ISIN: INE630Y01024 | SECTOR: Biotechnology & DrugsOpen
46.80High
47.00Low
46.50Prev Close
46.89P/E
-Median P/E
-P/B
-Median P/B
-Market Cap
3.86BVolume
8.31KVol. (20 day Avg.)
0PEG
-Div.Yield
-Bid
-Ask
-
Company Description
- Biotechnology & Drugs
BSE
540937NSE
MEDICOISIN
INE630Y01024
Medico Remedies Limited is an India-based pharmaceutical formulation manufacturing company. The Company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. It has manufacturing and marketing capabilities in formulation with focus on anti-infective, Beta-Lactums, cephalosporins, antimalarial, antiretroviral, anti-ulcer drugs and antacids, vitamins, haematinics and other supplements. In addition, the Company also manufactures other drugs, such as non-steroidal anti-inflammatory drugs (NSAIDS), antihistaminic, anti-diabetics, cardiovascular drugs, diuretics, anti-epileptics, combination drug kits, syrups and cream, and gel for various therapeutic segments. Its products include Doxycycline Capsules, Zenof-400 (Ofloxacin Tablets 400mg), Azithromycin Tablets, Aciclovir Tablets, Cipta Tablets, Cotrimoxazole Tablets, Tos Syrup, Paediatric Co-Trimozole Oral, Med Reactin (Cyproheptadine), and Medivit Syrup, among others.
Company Officers
Haresh Mehta
Chairman of the Board, Legal Head and Chief Financial OfficerHarshit Mehta
Managing Director, Marketing & Export Head and Executive DirectorRishit Mehta
Production - Technical & Quality Control Head and Whole-time DirectorRita Mehta
Office Administration Head and Whole-Time DirectorGopal Jha
Administration ManagerPriyal Mehta
Marketing ManagerDushant Pandey
Quality Control ManagerDinesh Modi
Company Secretary